SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
-8.57%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$181M
AUM Growth
+$181M
(-23%)
Cap. Flow
-$27.9M
Cap. Flow
% of AUM
-15.43%
Top 10 Holdings %
Top 10 Hldgs %
48.21%
Holding
48
New
12
Increased
6
Reduced
16
Closed
9
Top Buys
| 1 |
UnitedHealth
UNH
|
$6.32M |
| 2 |
Waters Corp
WAT
|
$5.19M |
| 3 |
Agilent Technologies
A
|
$4.7M |
| 4 |
AbbVie
ABBV
|
$4.44M |
| 5 |
Bristol-Myers Squibb
BMY
|
$3.96M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$9.01M |
| 2 |
Intuitive Surgical
ISRG
|
$8.6M |
| 3 |
Becton Dickinson
BDX
|
$6.03M |
| 4 |
Baxter International
BAX
|
$5.7M |
| 5 |
Medtronic
MDT
|
$5.4M |
Sector Composition
| 1 | Healthcare | 90.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SPDR S&P Biotech ETF
XBI
$5.07B
| $18M | 9.48% | 200,000 -100,000 | -33% | -$9.01M |
|
2
Eli Lilly
LLY
$657B
| $11.6M | 6.1% | 15,000 +500 | +3% | +$386K |
|
3
Boston Scientific
BSX
$156B
| $9.83M | 5.17% | 110,000 +5,000 | +5% | +$447K |
|
4
McKesson
MCK
$85.4B
| $8.55M | 4.5% | 15,000 -5,000 | -25% | -$2.85M |
|
5
Stryker
SYK
$150B
| $7.2M | 3.79% | 20,000 -7,000 | -26% | -$2.52M |
|
6
Tenet Healthcare
THC
$16.3B
| $6.94M | 3.66% | 55,000 -10,000 | -15% | -$1.26M |
|
7
Universal Health Services
UHS
$11.6B
| $6.73M | 3.54% | 37,500 -7,500 | -17% | -$1.35M |
|
|
8
UnitedHealth
UNH
$281B
| $6.32M | 3.33% | +12,500 | New | +$6.32M |
|
9
Novo Nordisk
NVO
$251B
| $6.02M | 3.17% | 70,000 -20,000 | -22% | -$1.72M |
|
10
HCA Healthcare
HCA
$94.5B
| $6M | 3.16% | 20,000 | – | – |
|
11
Cardinal Health
CAH
$35.5B
| $5.91M | 3.11% | 50,000 +5,000 | +11% | +$591K |
|
12
Danaher
DHR
$147B
| $5.74M | 3.02% | 25,000 -5,000 | -17% | -$1.15M |
|
13
Abbott
ABT
$231B
| $5.66M | 2.98% | 50,000 -10,000 | -17% | -$1.13M |
|
14
Cencora
COR
$56.5B
| $5.62M | 2.96% | 25,000 | – | – |
|
15
Vertex Pharmaceuticals
VRTX
$100B
| $5.24M | 2.76% | 13,000 +3,000 | +30% | +$1.21M |
|
|
16
Waters Corp
WAT
$18B
| $5.19M | 2.74% | +14,000 | New | +$5.19M |
|
17
Humana
HUM
$36.5B
| $5.07M | 2.67% | 20,000 +10,000 | +100% | +$2.54M |
|
|
18
Agilent Technologies
A
$35.7B
| $4.7M | 2.48% | +35,000 | New | +$4.7M |
|
|
19
AbbVie
ABBV
$372B
| $4.44M | 2.34% | +25,000 | New | +$4.44M |
|
20
Surgery Partners
SGRY
$2.91B
| $4.23M | 2.23% | 200,000 -30,000 | -13% | -$635K |
|
21
Avantor
AVTR
$9.18B
| $4.21M | 2.22% | 200,000 -50,000 | -20% | -$1.05M |
|
22
Encompass Health
EHC
$12.3B
| $4.16M | 2.19% | 45,000 -5,000 | -10% | -$462K |
|
|
23
Bristol-Myers Squibb
BMY
$96B
| $3.96M | 2.08% | +70,000 | New | +$3.96M |
|
24
Edwards Lifesciences
EW
$47.8B
| $3.7M | 1.95% | +50,000 | New | +$3.7M |
|
25
Cigna
CI
$80.3B
| $3.31M | 1.75% | +12,000 | New | +$3.31M |
|